Talphera

(NASDAQ) ACRX

Current PriceN/A

Market CapN/A

Since IPO (2011)-99%

5 Year-97%

1 Year+59%

1 Month+3%

Talphera Financials at a Glance

Market Cap

N/A

Revenue (TTM)

$28.00K

Net Income (TTM)

$14.29M

EPS (TTM)

N/A

P/E Ratio

N/A

Dividend

N/A

Beta (Volatility)

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

Dividend

N/A

Beta (Volatility)

N/A

Price

N/A

Volume

N/A

Open

N/A

Previous Close

N/A

Daily Range

N/A

52-Week Range

N/A

ACRX News

Page 1

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Talphera

Industry

Pharmaceuticals

Sector

Health Care

Employees

CEO

Vincent J. Angotti, MBA

Website

talphera.com

Headquarters

Hayward, CA 94545, US

ACRX Financials

Key Financial Metrics (TTM)

Gross Margin

-41%

Operating Margin

-482%

Net Income Margin

-510%

Return on Equity

-1%

Return on Capital

-52%

Return on Assets

-48%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

N/A

Shares Outstanding

N/A

Volume

N/A

Avg. Volume

N/A

Financials (TTM)

Gross Profit

$0.00

Operating Income

$13.48M

EBITDA

$13.48M

Operating Cash Flow

$11.36M

Capital Expenditure

$0.00

Free Cash Flow

$11.36M

Cash & ST Invst.

$20.38M

Total Debt

$0.00

Talphera Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q4 2025YOY CHG

Revenue

$0.00

+100.0%

Gross Profit

$0.00

-100.0%

Gross Margin

0.00%

N/A

Market Cap

N/A

Market Cap/Employee

N/A

Employees

N/A

Net Income

$3.77M

-101.7%

EBITDA

$2.44M

+18.6%

Quarterly Fundamentals

Name

Q4 2025YOY CHG

Net Cash

$20.38M

+130.0%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-48.08%

N/A

Return on Invested Capital

-52.04%

N/A

Free Cash Flow

$2.44M

-353.8%

Operating Cash Flow

$2.44M

-383.3%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

EMHTFEmerald Health Therapeutics, Inc.

EMHTFEmerald Health Therapeutics, Inc.$0.04+55.17%

CNPOFRIV Capital Inc.

CNPOFRIV Capital Inc.$0.08+0.00%

NLTXNeoleukin Therapeutics, Inc.

NLTXNeoleukin Therapeutics, Inc.$3.49+1.45%

RWBYFRed White & Bloom Brands Inc.

RWBYFRed White & Bloom Brands Inc.$0.03+1.82%

MGCLFMGC Pharmaceuticals Limited

MGCLFMGC Pharmaceuticals Limited$0.27+2.88%

EXDIExactus, Inc.

EXDIExactus, Inc.$0.07-10.96%

TLGTQTeligent, Inc.

TLGTQTeligent, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

SOFISoFi Technologies

SOFISoFi Technologies$15.53-0.15%

NOKNokia

NOKNokia$12.46+0.10%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.14+0.04%

KALVKalVista Pharmaceuticals

KALVKalVista Pharmaceuticals$26.67+0.39%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$61.86+0.02%

POETPoet Technologies

POETPoet Technologies$6.60-0.18%

ONDSOndas

ONDSOndas$9.49-0.09%

Questions About ACRX

What is the current price of Talphera?

Talphera is trading at N/A per share.

What is the 52-week range for Talphera?

Over the past 52 weeks, Talphera has traded between N/A and N/A.

How much debt does Talphera have?

As of the most recent reporting period, Talphera reported total debt of $6.50M.

How much cash does Talphera have on hand?

Talphera reported $5.89M in cash and cash equivalents in its most recent financial results.

What is Talphera’s dividend yield?

Talphera does not currently have a dividend yield.

Talphera

Talphera Financials at a Glance

ACRX News

Talphera Cuts Expenses 14 Percent

Talphera Cuts Costs and Speeds Trial

2 Penny Stocks That Could Make You Filthy Rich

Why AcelRx Pharmaceuticals Stock Is Sinking Today

Here's Why AcelRx Pharmaceuticals Fell as Much as 14% Today

3 Stocks Peter Lynch Would Love

Why AcelRx Pharmaceuticals Stock Is Sinking Today

3 Top Small-Cap Stocks to Buy Right Now

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Talphera

ACRX Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Talphera Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ACRX

What is the current price of Talphera?

What is the 52-week range for Talphera?

How much debt does Talphera have?

How much cash does Talphera have on hand?

What is Talphera’s dividend yield?

Premium Investing Services